Tuesday, Apr 23 2024 | Time 16:02 Hrs(IST)
image
Business EconomyPosted at: Mar 18 2019 4:42PM


TCG Lifesciences receives U.S. FDA approval for Hyderabad based chemical facility

Hyderabad, Mar 18 (UNI) TCG Lifesciences, part of New York based The Chatterjee Group, promoted by Dr Purnendu Chatterjee on Monday announced that it has received the US FDA approval for its chemical development and manufacturing facility in Hyderabad.

Supported by a strong talent pool of over 800 qualified scientists of TCG Lifesciences, Clininvent Research Private Limited, the 100 percent subsidiary of the company, has successfully passed a pre-approval inspection as a manufacturing plant, by the US Food and Drug Administration (USFDA). The inspection confirmed the site to be compliant with the principles and guidelines of Good Manufacturing Practices (GMP).

The chemical development and manufacturing facility is located at Anantaram here and boasts of manufacturing advanced intermediates and Regulatory Starting Materials (RSMs) and custom manufacturing of New Chemical Entities (NCEs). The plant is equipped with multiple reactors totaling of a huge scale of production capacity.

Speaking on the occasion, TCG Lifesciences Managing Director Swapan Bhattacharya said “This marks another important step for the TCG group in providing the US customers with innovative, high quality and integrated small molecule cGMP drug development synthesis services, covering IND enabling studies, clinical trials, and commercial production. At the same time, it marks our entry into the high growth generic APIs and intermediates domain for regulated markets. The key differentiators for TCGLS are our ability to handle very complex synthesis challenges, deliver comprehensive CMC packages and implement high end analytical and regulatory quality systems.”

“The pre-approval inspection was triggered by a DMF filing by one of our clients and subsequent ANDA filing” mentioned Subho Roy, Vice President, TCG Lifesciences. “It is an extremely satisfying result for our team and customers. Getting USFDA approval within 2 years of its inception proves the commitment of the Clininvent team and the ability to meet the highest quality standards in the manufacturing of critical products,” he added.
UNI VV CS 1642
Please log in to get detailed story.
Tags: #TCG Lifesciences receives U.S. FDA approval for Hyderabad based chemical facility
More News
Rupee rises 3 paise against USD

Rupee rises 3 paise against USD

23 Apr 2024 | 11:35 AM

Mumbai, Apr 23 (UNI) The rupee continued to rise on Tuesday too, as it advanced 3 paise to 83.34 in the opening session on the selling of US dollars by bankers and exporters, dealers at the Foreign Exchange said.

see more..
Sensex up 400 points

Sensex up 400 points

23 Apr 2024 | 11:35 AM

Mumbai, Apr 23 (UNI) Extending the rally for the third consecutive day, the BSE Sensex on Tuesday spurted 400 points to open at 74,048.94 as buying was seen across the board.

see more..
Air India and All Nippon Airways to begin codeshare partnership for travel between India and Japan

Air India and All Nippon Airways to begin codeshare partnership for travel between India and Japan

23 Apr 2024 | 11:19 AM

GURUGRAM, Apr 23 (UNI) Air India, India’s leading global airline, and All Nippon Airways, the largest Japanese carrier, have signed a codeshare agreement connecting their networks.

see more..

Major Currencies down

23 Apr 2024 | 10:29 AM

Mumbai, Apr 23 (UNI) Following were the indicative currency rates and travellers' cheques
buying and selling rates.

see more..

RINL-VSP seeks help from all stakeholders in resolving severe coal crisis

22 Apr 2024 | 8:28 PM

Visakhapatnam (Andhra Pradesh), April 22 (UNI) In the backdrop of a severe coal crisis due to the halt in operations at Adani Gangavaram Port Limited (AGPL), Rashtriya Ispat Nigam Limited (RINL), popularly known as Visakhapatnam Steel Plant (VSP), on Monday requested all citizens, stakeholders, contract workers, and people's representatives to come together and assist the plant in resolving the coal crisis.

see more..
image